Search
for
Sort by
Research 361–390 of 485
- Acne Vulgaris
- Toxic and Metabolic Disorders of the Nervous System
- Female pattern hair loss: therapeutic update
- The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review
- COVID-19: Pulmonary and Extra Pulmonary Manifestations
- K channel therapeutics at the bedside
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Inflammatory bowel disease: pathogenesis, diagnosis and current therapeutic approach
- Female pattern hair loss
- FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial
- Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Management of transgender patients in critical care
- Hypoparathyroidism as the single major component for decades of autoimmune polyglandular syndrome type 1
- Disproportionality analysis comparing safety profiles of sonidegib and vismodegib based on the FAERS database
- Hirsutism-A Comprehensive Update of Embryology, Aetiopathogenesis and Therapeutic Approach
- Acne vulgaris: recognition and management
- Short‐Term, Low‐Dose Spironolactone for Treatment of Hyperandrogenic Symptoms of Polycystic Ovary Syndrome—A Systematic Review
- Male and female pattern hair loss
- Nanotechnology-based techniques for hair follicle regeneration
- The Transgender: Endocrinological Assessment
- The Rotterdam Study: objectives and design update
- Corticosteroids for the treatment of Duchenne muscular dystrophy
- New aspects of vitamin D metabolism and action — addressing the skin as source and target
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Vitamin D: More Than a “Bone-a-Fide” Hormone
- APCDD1 is a novel Wnt inhibitor mutated in hereditary hypotrichosis simplex
- European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
- Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
- Phytochemistry, pharmacological activity, and potential health benefits of Glycyrrhiza glabra